Scott J. Charles
2016
In 2016, Scott J. Charles earned a total compensation of $2.2M as Chief Financial Officer, at Aralez Pharmaceuticals, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $66,540 |
| Salary | $400,000 |
| Stock Awards | $1,014,194 |
| Other | $545,688 |
| Total | $2,206,422 |
Charles received $1M in stock awards, accounting for 46% of the total pay in 2016.
Charles also received $180K in non-equity incentive plan, $66.5K in option awards, $400K in salary and $545.7K in other compensation.
Rankings
In 2016, Scott J. Charles' compensation ranked 4,447th out of 14,075 executives tracked by ExecPay. In other words, Charles earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,447 out of 14,075 | 68th |
Division Manufacturing | 1,564 out of 5,488 | 72nd |
Major group Chemicals And Allied Products | 474 out of 1,900 | 75th |
Industry group Drugs | 346 out of 1,543 | 78th |
Industry Pharmaceutical Preparations | 270 out of 1,173 | 77th |
Source: SEC filing on March 23, 2017.
Charles' colleagues
We found four more compensation records of executives who worked with Scott J. Charles at Aralez Pharmaceuticals in 2016.